Literature DB >> 35107486

NEW CLASSIFICATION FOR ESOPHAGEAL MOTILITY DISORDERS (CHICAGO CLASSIFICATION VERSION 4.0©) AND CHAGAS DISEASE ESOPHAGOPATHY (ACHALASIA).

Fernando Augusto Mardiros Herbella1, Osvaldo Malafaia2, Marco G Patti3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35107486      PMCID: PMC8846476          DOI: 10.1590/0102-672020210002e1624

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


× No keyword cloud information.
High-resolution manometry (HRM) is undoubtedly an evolution of conventional manometry. This technology was developed at the beginning of the century, even though it reached Latin America only in 2008 . Esophageal motility testing became at least more comfortable and intuitive for the nonexpert after HRM; however, an abundance of new parameters and diagnosis was agreeable to the eye presentation of the colorful plots. A consensus became mandatory and a panel of experts started to release periodic guidelines for HRM interpretation, the so-called Chicago Classification. A new version has just been published with some practical implications for surgeons . In this new version, the diagnosis of achalasia is still defined by abnormal relaxation of the lower esophageal sphincter (LES) as measured by an elevated integrated relaxation pressure (IRP) and the division of subtypes based on esophageal pressurization is kept unaltered. Different from the previous versions, however, some situations define an “inconclusive diagnosis of achalasia” as (a) absent contractility with no appreciable peristalsis in the setting of IRP values at the upper limit of normal; (b) evidence of appreciable peristalsis with changing position in the setting of a type I or II achalasia pattern; and (c) an abnormal IRP with evidence of spasm and evidence of peristalsis in the setting of a type III achalasia pattern. Let us discuss the implications of these assertions in the management of patients with Chagas disease esophagopathy (CDE; achalasia) since HRM is currently more disseminated in Brazil since national systems were developed . The first point for discussion is that the conclusive diagnosis of achalasia is based on aperistalsis. The all or nothing at all concept is still valid for the conclusive manometric diagnosis of achalasia. Some authors have not been applying this criterion in patients with CDE . An “undetermined” phase of CDE is usually quoted as a common finding in patients with CDE . Whether these cases truly represent a predisease to progress to complete aperistalsis is elusive. On the one hand, researchers who have the chance to study patients with positive serological tests for CDE before esophageal symptoms may manifest what does not occur in idiopathic achalasia. On the other hand, patients with Chagas disease may never develop CDE but may present with other esophageal diseases such as gastroesophageal reflux disease (GERD) . Chicago Classification 4.0 clarified that primary esophageal motility disorders should only be considered in the absence of GERD and, as such, all these cases of an “undetermined” phase must undergo pH monitoring. One must be aware that pseudoreflux may occur in achalasia due to food fermentation in the esophagus, but tracings are very characteristic of this occurrence . The second point for discussion is that “inconclusive diagnosis of achalasia” according to Chicago Classification 4.0 does not contemplate the cases usually considered as “undetermined” phase. The first situation for inconclusive diagnosis is the presence of aperistalsis and IRP values at the upper limit of normal. Even though there was no definition for the upper limit, it is not uncommon to find with proved CDE and normal IRP values, especially in the setting of a hypotonic LES . Moreover, surgeons are used to treat patients after the failure of endoscopic therapy when the parameter of the LES is lost . Another situation is the presence of peristalsis when the manometry is repeated in a different position (supine vs. upright). In our opinion, this may represent a misinterpretation of the test rather than a peculiar diagnosis. Finally, there is reference to specific situations facing type III achalasia pattern that is not found in CDE since there is an impaired tonic effect of cholinergic nerves on the smooth muscle of the esophagus . Brazilian surgeons always believed on a complete workup to manage CDE rather than simply on manometric diagnosis . Chicago Classification 4.0 only corroborates this belief.
  10 in total

1.  Nissen fundoplication for the treatment of gastroesophageal reflux disease in patients with Chagas disease without achalasia.

Authors:  Carlos A R Pantanali; Fernando A M Herbella; Maria A C A Henry; Jose L B Aquino; Jose Francisco Mattos Farah; Jose C Del Grande
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2010 Mar-Apr       Impact factor: 1.846

2.  High-resolution manometry classifications for idiopathic achalasia in patients with Chagas' disease esophagopathy.

Authors:  Fernando P P Vicentine; Fernando A M Herbella; Marco E Allaix; Luciana C Silva; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

3.  Chicago classification version 4.0© from surgeons' point of view.

Authors:  Fernando Augusto Mardiros Herbella; Marco G Patti
Journal:  Neurogastroenterol Motil       Date:  2021-01-27       Impact factor: 3.598

4.  Esophageal motility of patients with Chagas' disease and idiopathic achalasia.

Authors:  R O Dantas; N H Deghaide; E A Donadi
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

5.  Comparison of idiopathic achalasia and Chagas' disease esophagopathy at the light of high-resolution manometry.

Authors:  F P P Vicentine; F A M Herbella; M E Allaix; L C Silva; M G Patti
Journal:  Dis Esophagus       Date:  2013-06-24       Impact factor: 3.429

6.  VALIDATION OF A NEW WATER-PERFUSED HIGH-RESOLUTION MANOMETRY SYSTEM.

Authors:  Rogério Mariotto; Fernando A M Herbella; Vera Lucia Ângelo Andrade; Francisco Schlottmann; Marco G Patti
Journal:  Arq Bras Cir Dig       Date:  2021-01-25

7.  Importance of preoperative and postoperative pH monitoring in patients with esophageal achalasia.

Authors:  M G Patti; M Arcerito; J Tong; A Wang; C V Feo; S J Mulvihill; L W Way
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

Review 8.  Treatment of achalasia: lessons learned with Chagas' disease.

Authors:  F A M Herbella; J L B Aquino; S Stefani-Nakano; E L A Artifon; P Sakai; E Crema; N A Andreollo; L R Lopes; C de Castro Pochini; P R Corsi; D Gagliardi; J C Del Grande
Journal:  Dis Esophagus       Date:  2008-04-22       Impact factor: 3.429

Review 9.  Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©.

Authors:  Rena Yadlapati; Peter J Kahrilas; Mark R Fox; Albert J Bredenoord; C Prakash Gyawali; Sabine Roman; Arash Babaei; Ravinder K Mittal; Nathalie Rommel; Edoardo Savarino; Daniel Sifrim; André Smout; Michael F Vaezi; Frank Zerbib; Junichi Akiyama; Shobna Bhatia; Serhat Bor; Dustin A Carlson; Joan W Chen; Daniel Cisternas; Charles Cock; Enrique Coss-Adame; Nicola de Bortoli; Claudia Defilippi; Ronnie Fass; Uday C Ghoshal; Sutep Gonlachanvit; Albis Hani; Geoffrey S Hebbard; Kee Wook Jung; Philip Katz; David A Katzka; Abraham Khan; Geoffrey Paul Kohn; Adriana Lazarescu; Johannes Lengliner; Sumeet K Mittal; Taher Omari; Moo In Park; Roberto Penagini; Daniel Pohl; Joel E Richter; Jordi Serra; Rami Sweis; Jan Tack; Roger P Tatum; Radu Tutuian; Marcelo F Vela; Reuben K Wong; Justin C Wu; Yinglian Xiao; John E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2021-01       Impact factor: 3.598

10.  Esophageal transit time in patients with chagasic megaesophagus: Lack of linear correlation between dysphagia and grade of dilatation.

Authors:  Paula Martins; Cid Sergio Ferreira; José Renan Cunha-Melo
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.